FDTRX Mutual Fund Forecast & Price Targets

Compare

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

FDTRX Analyst Rating

Strong Buy

121 Buy

8 Hold

0 Sell

Based on the consensus analyst ratings on 129 stocks held in FDTRX.

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

FDTRX Analyst Price Target

Average Price Target

$206.77

Based on 129 Wall Street analysts offering 12 month price targets to Franlin DynaTech Fund Cl R6 holdings in the last 3 months. The average price target is $206.77 with a high forecast of $250.50 and a low forecast of $158.33. The average price target represents a 26.26% change from the last price of $163.76.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"152":"$152","251":"$251","176.75":"$176.8","201.5":"$201.5","226.25":"$226.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":250.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$250.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":206.768,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$206.77</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":158.325,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$158.32</span>\n  </div></div>","useHTML":true}}],"tickPositions":[152,176.75,201.5,226.25,251],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2024","6":"Oct<br/>2024","9":"Jan<br/>2025","12":"Apr<br/>2025","25":"Apr<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n              \n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,164.41,171.03230769230768,177.65461538461537,184.27692307692308,190.89923076923077,197.52153846153846,204.14384615384614,210.76615384615383,217.38846153846154,224.01076923076923,230.6330769230769,237.25538461538463,243.8776923076923,{"y":250.5,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,164.41,167.66830769230768,170.9266153846154,174.18492307692307,177.44323076923078,180.70153846153846,183.95984615384614,187.21815384615385,190.47646153846154,193.73476923076925,196.99307692307693,200.2513846153846,203.50969230769232,{"y":206.768,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,164.41,163.94192307692308,163.47384615384615,163.00576923076923,162.5376923076923,162.0696153846154,161.60153846153847,161.13346153846152,160.6653846153846,160.19730769230767,159.72923076923075,159.26115384615383,158.7930769230769,{"y":158.325,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":163.03,"date":1711929600000,"info":"<div>Price: <b>$163<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":153.41,"date":1714521600000,"info":"<div>Price: <b>$153<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":163.65,"date":1717372800000,"info":"<div>Price: <b>$164<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":175.12,"date":1719792000000,"info":"<div>Price: <b>$175<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":164.98,"date":1722470400000,"info":"<div>Price: <b>$165<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":166.08,"date":1725321600000,"info":"<div>Price: <b>$166<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":173.53,"date":1727740800000,"info":"<div>Price: <b>$174<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":177.31,"date":1730419200000,"info":"<div>Price: <b>$177<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":189.01,"date":1733097600000,"info":"<div>Price: <b>$189<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":186.54,"date":1735776000000,"info":"<div>Price: <b>$187<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":189.88,"date":1738540800000,"info":"<div>Price: <b>$190<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":175.16,"date":1740960000000,"info":"<div>Price: <b>$175<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":164.41,"date":1743465600000,"info":"<div>Price: <b>$164<b/></div>","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$250.50

Average Price Target$206.77

Lowest Price Target$158.33

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

FDTRX Stocks With Highest Upside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

CRNX

Crinetics Pharma

11 Buy

1 Hold

0 Sell

Strong Buy

$78.20

xxxxxxxxxxxxxxxxxxxxxxxxxxx

RARE

Ultragenyx Pharmaceutical, Inc.

15 Buy

1 Hold

0 Sell

Strong Buy

$90.43

xxxxxxxxxxxxxxxxxxxxxxxxxxx

ARGX

arGEN X

6 Buy

2 Hold

0 Sell

Strong Buy

$681.13

xxxxxxxxxxxxxxxxxxxxxxxxxxx

MRVL

Marvell Technology Group

27 Buy

2 Hold

0 Sell

Strong Buy

$104.23

xxxxxxxxxxxxxxxxxxxxxxxxxxx

TTD

Trade Desk

21 Buy

7 Hold

0 Sell

Strong Buy

$94.71

FDTRX Stocks With Highest Downside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

PLTR

Palantir Technologies Inc.

3 Buy

12 Hold

3 Sell

Hold

$93.69

xxxxxxxxxxxxxxxxxxxxxxxxxxx

TTAN

ServiceTitan, Inc. Class A

9 Buy

4 Hold

0 Sell

Moderate Buy

$116.55

xxxxxxxxxxxxxxxxxxxxxxxxxxx

CRWD

Crowdstrike Holdings

34 Buy

3 Hold

0 Sell

Strong Buy

$420.68

xxxxxxxxxxxxxxxxxxxxxxxxxxx

ITCI

Intra-Cellular Therapies

4 Buy

9 Hold

0 Sell

Moderate Buy

$130.83

xxxxxxxxxxxxxxxxxxxxxxxxxxx

TSLA

Tesla Motors

17 Buy

11 Hold

12 Sell

Hold

$284.74

FDTRX Mutual Fund FAQ

What is FDTRX’s average 12-month price target, according to analysts?

Based on analyst ratings, Franlin DynaTech Fund Cl R6’s 12-month average price target is 206.77.

What is FDTRX’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for FDTRX, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is FDTRX a Buy, Sell or Hold?

Franlin DynaTech Fund Cl R6 has a consensus rating of Strong Buy which is based on 121 buy ratings, 8 hold ratings and 0 sell ratings.

What is Franlin DynaTech Fund Cl R6’s price target?

The average price target for Franlin DynaTech Fund Cl R6 is 206.77. This is based on 129 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $250.50 ,the lowest forecast is $158.33. The average price target represents N/A Increase from the current price of N/A.

What do analysts say about Franlin DynaTech Fund Cl R6?

Franlin DynaTech Fund Cl R6’s analyst rating consensus is a Strong Buy. This is based on the ratings of 129 Wall Streets Analysts.

How can I buy shares of FDTRX?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing